UnitedHealth Group (NYSE:UNH) Shares Unloaded Sen. Angus S. King Jr.

Senator Angus S. King Jr. (I-Maine) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on August 18th, the Senator disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 15th.

Senator Angus S. King Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Kirby (NYSE:KEX) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Lowe’s Companies (NYSE:LOW) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOGL) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Exxon Mobil (NYSE:XOM) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Uber Technologies (NYSE:UBER) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of Netflix (NASDAQ:NFLX) on 7/21/2025.
• Purchased $1,001 – $15,000 in shares of PayPal (NASDAQ:PYPL) on 7/21/2025.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $2.0280 during mid-day trading on Monday, reaching $305.3920. 3,172,398 shares of the company’s stock traded hands, compared to its average volume of 12,807,723. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The firm has a 50 day moving average price of $288.39 and a two-hundred day moving average price of $387.54. The firm has a market capitalization of $276.58 billion, a PE ratio of 13.23, a price-to-earnings-growth ratio of 1.98 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter last year, the firm posted $6.80 EPS. The firm’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group’s payout ratio is presently 38.30%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on UNH. Wall Street Zen downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a report on Wednesday, May 14th. TD Securities reiterated a “hold” rating and set a $308.00 price objective (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Robert W. Baird reiterated an “underperform” rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Finally, Morgan Stanley cut their price target on shares of UnitedHealth Group from $342.00 to $325.00 and set an “overweight” rating on the stock in a report on Wednesday, August 20th. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Financial Management Professionals Inc. boosted its position in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares in the last quarter. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC raised its position in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after purchasing an additional 21 shares during the last quarter. Retirement Planning Group LLC raised its stake in shares of UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after purchasing an additional 21 shares during the last quarter. Finally, Net Worth Advisory Group raised its stake in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock worth $1,907,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.28% of the stock is currently owned by insiders.

About Senator King

Angus King (independent) is a member of the U.S. Senate from Maine. He assumed office on January 3, 2013. His current term ends on January 3, 2031.

King (independent) ran for re-election to the U.S. Senate to represent Maine. He won in the general election on November 5, 2024.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.